---
$id: https://graph.org.ai/products/commodity/51111860
$type: Product
source: UNSPSC
code: "51111860"
title: "Mitotane"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mitotane

**UNSPSC Code**: 51111860
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-adrenal with the molecular formula C14H10Cl4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78E4J5IB5J, chemically known as 2,4-dichlorophenyldichlorethane but generally known as mitotane, which bears US NIH Compound Identifier 4211. European Medicines Agency schedules Mitotane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09010MIG. The term MITOTANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules mitotane in its Anatomical Therapeutic Chemical (ATC) Classification. MITOTANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, MITOTANE remains the US FDA Preferred Term for this commodity. Mitotane bears US NLM identifiers UMLS ID C0026256 and NCI Concept Code C664. SMILES: CLC(CL)C(C1CCC(CL)CC1)C1C(CL)CCCC1.

